RF Ablation of Treatment of Metastatic Lesions in Patients Undergoing Antiangiogenic Therapy for Stage IV Renal Cell Carcinoma
- Status
- WITHDRAWN
- Phase
- NA
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
Treatment of Advanced Renal Cell Carcinoma With Quinacrine
- Status
- WITHDRAWN
- Phase
- PHASE2
A Phase 1b, Open-Label, Dose-Finding Study to Evaluate the Safety of Tivozanib (AV-951) in Combination With Temsirolimus in Subjects With Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
LBH589 Treatment for Refractory Clear Cell Renal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
IMA901 in Advanced Renal Cell Carcinoma Patients With Measurable Disease
- Status
- COMPLETED
- Phase
- PHASE2
Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia
- Status
- COMPLETED
- Phase
- N/A
Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating the Efficacy and Safety of Sunitinib With or Without Bevacizumab in First-Line Patients With Metastatic Renal Cell Cancer (SABRE-R)
- Status
- TERMINATED
- Phase
- PHASE2
Pemetrexed Plus Gemcitabine in Renal Cell Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Zoledronate With Atorvastatin in Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Neoadjuvant Sutent for Patients With Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Kidney Removal
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Sorafenib in Advanced Renal Cell Carcinoma (RCC)
- Status
- COMPLETED
- Phase
- PHASE3
Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib
- Status
- COMPLETED
- Phase
- PHASE3
SUTENT® In The First Line Treatment Of Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A